S. Fleury

Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia.

A. Bura, L. Casteilla, P. Bourin, 2014, Cytotherapy.

Early efficacy evaluation of mesenchymal stromal cells (MSC) combined to biomaterials to treat long bone non-unions.

E. Gómez-Barrena, N. Baldini, M. Huber-Lang, 2020, Injury.

Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial.

E. Gómez-Barrena, N. Baldini, M. Huber-Lang, 2019, Biomaterials.

Adipose Mesenchymal Stromal Cell‐Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose‐Escalation Trial

F. Canovas, F. Barry, G. Lisignoli, 2016, Stem cells translational medicine.

Paracrine Potential of the Human Adipose Tissue-Derived Stem Cells to Modulate Balance between Matrix Metalloproteinases and Their Inhibitors in the Osteoarthritic Cartilage In Vitro

J. Denkovskij, E. Bernotiene, C. Jorgensen, 2017, Stem cells international.